Mark J. Ratain

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Patent claim landscape of FDA Orange Book–listed oral oncology drugs: A systematic analysis of standard practice claims.

  Journal of Clinical Oncology · 2026-05-28

• Social risk factors and treatment preferences for patients with breast cancer.

  Journal of Clinical Oncology · 2026-05-28

• Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic Consultation

  Clinical and Translational Science · 2026-04-01

• Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal Cancer

  Journal of Clinical Oncology · 2025-12-05

• Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)

  UNC Libraries · 2025-11-18

• Genome‐wide association studies of survival in 1520 cancer patients treated with bevacizumab‐containing regimens

  UNC Libraries · 2025-10-24

• Potential alternative dosage strategies for patent-protected oral cancer drugs

  European Journal of Cancer · 2025-10-20

• Strengthening the Food and Drug Administration Office of Clinical Pharmacology's Labeling Authority

  Clinical and Translational Science · 2025-08-26 · 1 citations

• Results of the <scp>ACCOuNT</scp> Trial: A Multi‐Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients

  Clinical Pharmacology & Therapeutics · 2025-08-22 · 1 citations

• ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia

  UNC Libraries · 2025-07-24

• Totality of the Evidence: Optimizing Dosage Selection Strategies in Oncology

  Journal of Clinical Oncology · 2025-07-24 · 6 citations

• Impact of First‐of‐Its‐Kind Patient‐Facing Pharmacogenetics Tool on Dosing Decisions and Treatment Outcomes

  Clinical Pharmacology & Therapeutics · 2025-06-27

• Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs

  Clinical Pharmacology & Therapeutics · 2025-06-05 · 1 citations

• Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

  UNC Libraries · 2025-05-23

• Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients

  UNC Libraries · 2025-05-23

• Triaging acute chest syndrome clinical decision-making using bedside SaO2/FiO2 ratio

  Blood Advances · 2025-04-03 · 3 citations

• Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient Prescribing

  Clinical and Translational Science · 2025-04-01 · 2 citations

• Missed Opportunity for Sotorasib Dose Optimization

  Journal of Clinical Oncology · 2025-02-06

• Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

  Communications Medicine · 2025-01-08 · 6 citations

• Non-inferiority trials: tyranny or good governance? – Authors' reply

  The Lancet Oncology · 2025-01-01